Hiệu quả về kinh tế của các phương pháp thay thế cho việc truyền máu
Huyết học (Ung thư)
Early intravenous iron administration in the Emergency Department reduces red blood cell unit transfusion, hospitalisation, re-transfusion, length of stay and costs. (mở cửa sổ mới)
Nguồn: Blood Transfus 2020;18(2):106-16.
Mã bài: PubMed 31855149
DOI: 10.2450/2019.0248-19
https://www.ncbi.nlm.nih.gov/pubmed/31855149 (mở cửa sổ mới)
Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe. (mở cửa sổ mới)
Nguồn: Support Care Cancer 2013;21(2):485-93.
Mã bài: PubMed 22825456
DOI: 10.1007/s00520-012-1538-0
https://www.ncbi.nlm.nih.gov/pubmed/22825456 (mở cửa sổ mới)
Restrictive blood transfusion practices are associated with improved patient outcomes. (mở cửa sổ mới)
Nguồn: Transfusion 2014;54(10 Pt 2):2753-9.
Mã bài: PubMed 24995770
DOI: 10.1111/trf.12723
https://www.ncbi.nlm.nih.gov/pubmed/24995770 (mở cửa sổ mới)
Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United Kingdom. (mở cửa sổ mới)
Nguồn: Clin Ther 2010;32(14):2478-93.
Mã bài: PubMed 21353116
DOI: 10.1016/j.clinthera.2011.01.011
https://www.ncbi.nlm.nih.gov/pubmed/21353116 (mở cửa sổ mới)
Recombinant activated factor VII use in critically ill infants with active hemorrhage. (mở cửa sổ mới)
Nguồn: J Pediatr Surg 2008;43(12):2235-8.
Mã bài: PubMed 19040942
DOI: 10.1016/j.jpedsurg.2008.08.053
https://www.ncbi.nlm.nih.gov/pubmed/19040942 (mở cửa sổ mới)
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (mở cửa sổ mới)
Nguồn: Blood Adv. 2022;6(3):785-92.
Mã bài: PubMed 34781363
DOI: 10.1182/bloodadvances.2021005627
Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program. (mở cửa sổ mới)
Nguồn: Transfusion 2017;57(9):2189-96.
Mã bài: PubMed 28671296
DOI: 10.1111/trf.14191
https://www.ncbi.nlm.nih.gov/pubmed/28671296 (mở cửa sổ mới)
Impact of a conservative red blood cell transfusion strategy in children undergoing hematopoietic stem cell transplantation. (mở cửa sổ mới)
Nguồn: Biol Blood Marrow Transplant 2012;18(5):813-7.
Mã bài: PubMed 22080050
DOI: 10.1016/j.bbmt.2011.10.043
https://www.ncbi.nlm.nih.gov/pubmed/22080050 (mở cửa sổ mới)
The cost of blood: a study of the total cost of red blood cell transfusion in patients with β-thalassemia using time-driven activity-based costing. (mở cửa sổ mới)
Nguồn: Transfusion 2019;59(11):3386-95.
Mã bài: PubMed 31664712
DOI: 10.1111/trf.15558
https://www.ncbi.nlm.nih.gov/pubmed/31664712 (mở cửa sổ mới)
Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (mở cửa sổ mới)
Nguồn: Transfusion 2015;55(12):2807-15.
Mã bài: PubMed 26264557
DOI: 10.1111/trf.13260
https://www.ncbi.nlm.nih.gov/pubmed/26264557 (mở cửa sổ mới)
Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (mở cửa sổ mới)
Nguồn: Cancer 2013;119(1):107-14.
Mã bài: PubMed 22744794
DOI: 10.1002/cncr.27686
https://www.ncbi.nlm.nih.gov/pubmed/22744794 (mở cửa sổ mới)
Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece. (mở cửa sổ mới)
Nguồn: Cost Eff Resour Alloc 2013;11(1):16.
Mã bài: PubMed 23870502
DOI: 10.1186/1478-7547-11-16
https://www.ncbi.nlm.nih.gov/pubmed/23870502 (mở cửa sổ mới)
Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia. (mở cửa sổ mới)
Nguồn: Support Care Cancer 2012;20(1):159-65.
Mã bài: PubMed 21359879
DOI: 10.1007/s00520-010-1083-7
https://www.ncbi.nlm.nih.gov/pubmed/21359879 (mở cửa sổ mới)
Comparative net cost impact of the utilization of romiplostim and intravenous immunoglobulin for the treatment of patients with immune thrombocytopenia in Québec, Canada. (mở cửa sổ mới)
Nguồn: J Med Econ 2013;16(2):318-26.
Mã bài: PubMed 23216012
DOI: 10.3111/13696998.2012.756400
https://www.ncbi.nlm.nih.gov/pubmed/23216012 (mở cửa sổ mới)
Blood transfusion versus hydroxyurea in beta-thalassemia in Iran: a cost-effectiveness study. (mở cửa sổ mới)
Nguồn: Hematology 2018;23(7):417-22.
Mã bài: PubMed 29157136
DOI: 10.1080/10245332.2017.1404262
https://www.ncbi.nlm.nih.gov/pubmed/29157136 (mở cửa sổ mới)
The burden of blood transfusion: a utilization and economic analysis--a pilot study in patients with chemotherapy-induced anemia (CIA). (mở cửa sổ mới)
Nguồn: J Med Econ 2013;16(5):633-8.
Mã bài: PubMed 23425291
DOI: 10.3111/13696998.2013.778269
https://www.ncbi.nlm.nih.gov/pubmed/23425291 (mở cửa sổ mới)
Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. (mở cửa sổ mới)
Nguồn: Transfusion 2010;50(2):487-92.
Mã bài: PubMed 19804569
DOI: 10.1111/j.1537-2995.2009.02413.x
https://www.ncbi.nlm.nih.gov/pubmed/19804569 (mở cửa sổ mới)
Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease. (mở cửa sổ mới)
Nguồn: Am J Hematol 2010;85(10):795-7.
Mã bài: PubMed 20645429
DOI: 10.1002/ajh.21772
https://www.ncbi.nlm.nih.gov/pubmed/20645429 (mở cửa sổ mới)
Increased hospital costs associated with red blood cell transfusion. (mở cửa sổ mới)
Nguồn: Transfusion 2015;55(5):1082-9.
Mã bài: PubMed 25488623
DOI: 10.1111/trf.12958
https://www.ncbi.nlm.nih.gov/pubmed/25488623 (mở cửa sổ mới)